Security key
427746102
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)
CUSIP: 427746102
Q1 2019 13F Holders as of 31 Mar 2019
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 182,615,507
- Total 13F shares
- 92,662,760
- Share change
- +1,221,068
- Total reported value
- $2,264,521,795
- Put/Call ratio
- 17%
- Price per share
- $24.44
- Number of holders
- 189
- Value change
- +$28,820,026
- Number of buys
- 104
- Number of sells
- 60
Report period
Q1 2019
Institutions
189
Top holders
10
HRTX full security history
Newer quarter: Q2 2019
Previous quarter: Q4 2018
HERON THERAPEUTICS, INC. /DE/ SEC filings
HERON THERAPEUTICS, INC. /DE/ company facts
Broader feeds
Reporting periods
Holder history for CUSIP 427746102
Recent filing periods:
Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC |
13F
|
Company |
4.6%
|
8,421,291
|
$218,356,000 | — | 31 Dec 2018 | |
| FMR LLC |
13F
|
Company |
4.4%
|
8,034,803
|
$208,423,000 | — | 31 Dec 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
6,314,339
|
$163,794,000 | — | 31 Dec 2018 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.2%
|
5,818,541
|
$150,933,000 | — | 31 Dec 2018 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3%
|
5,437,540
|
$141,050,000 | — | 31 Dec 2018 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.7%
|
5,018,104
|
$130,170,000 | — | 31 Dec 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
4,913,006
|
$127,443,000 | — | 31 Dec 2018 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.5%
|
4,577,871
|
$118,750,000 | — | 31 Dec 2018 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
3,485,992
|
$90,427,000 | — | 31 Dec 2018 | |
| Rubric Capital Management LP |
13F
|
Company |
1.5%
|
2,787,592
|
$72,310,000 | — | 31 Dec 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
2,642,103
|
$68,536,000 | — | 31 Dec 2018 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
2,482,309
|
$64,391,000 | — | 31 Dec 2018 | |
| FIL Ltd |
13F
|
Company |
1.2%
|
2,267,854
|
$58,828,000 | — | 31 Dec 2018 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.2%
|
2,225,050
|
$57,718,000 | — | 31 Dec 2018 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.92%
|
1,685,751
|
$43,728,000 | — | 31 Dec 2018 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.77%
|
1,400,300
|
$36,324,000 | — | 31 Dec 2018 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.7%
|
1,274,695
|
$33,066,000 | — | 31 Dec 2018 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.58%
|
1,066,263
|
$27,459,000 | — | 31 Dec 2018 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.58%
|
1,060,770
|
$27,516,000 | — | 31 Dec 2018 | |
| HIGHLAND CAPITAL MANAGEMENT LP |
13F
|
Company |
0.58%
|
1,059,792
|
$27,491,000 | — | 31 Dec 2018 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.58%
|
1,054,008
|
$27,341,000 | — | 31 Dec 2018 | |
| Carlson Capital, L.P. |
13F
|
Company |
0.54%
|
983,560
|
$25,514,000 | — | 31 Dec 2018 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.47%
|
860,552
|
$22,323,000 | — | 31 Dec 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
836,535
|
$21,701,000 | — | 31 Dec 2018 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.45%
|
825,269
|
$21,407,000 | — | 31 Dec 2018 | |
| NEXTHERA CAPITAL LP |
13F
|
Company |
0.45%
|
819,164
|
$21,249,000 | — | 31 Dec 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
751,250
|
$19,487,000 | — | 31 Dec 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
696,406
|
$18,064,000 | — | 31 Dec 2018 | |
| NORGES BANK |
13F
|
Company |
0.29%
|
527,351
|
$13,679,000 | — | 31 Dec 2018 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.29%
|
525,000
|
$13,619,000 | — | 31 Dec 2018 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.26%
|
470,872
|
$12,214,000 | — | 31 Dec 2018 | |
| S.c.a. Candriam |
13F
|
Individual |
0.25%
|
463,600
|
$12,025,000 | — | 31 Dec 2018 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.25%
|
459,262
|
$11,913,000 | — | 31 Dec 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.25%
|
447,930
|
$11,619,000 | — | 31 Dec 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
429,777
|
$11,149,000 | — | 31 Dec 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
381,505
|
$9,897,000 | — | 31 Dec 2018 | |
| Kavi Asset Management, LP |
13F
|
Company |
0.2%
|
369,030
|
$9,573,000 | — | 31 Dec 2018 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.2%
|
359,713
|
$9,331,000 | — | 31 Dec 2018 | |
| STELLIAM INVESTMENT MANAGEMENT, LP |
13F
|
Company |
0.19%
|
352,100
|
$9,133,000 | — | 31 Dec 2018 | |
| Tavio Capital LLC |
13F
|
Company |
0.17%
|
307,737
|
$7,983,000 | — | 31 Dec 2018 | |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.17%
|
303,606
|
$7,876,000 | — | 31 Dec 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
298,065
|
$7,732,000 | — | 31 Dec 2018 | |
| Invesco Ltd. |
13F
|
Company |
0.16%
|
288,885
|
$7,493,000 | — | 31 Dec 2018 | |
| Pier Capital, LLC |
13F
|
Company |
0.14%
|
253,600
|
$6,578,000 | — | 31 Dec 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.13%
|
239,891
|
$6,223,000 | — | 31 Dec 2018 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.13%
|
229,626
|
$5,956,000 | — | 31 Dec 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
217,295
|
$5,638,000 | — | 31 Dec 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.12%
|
212,342
|
$5,509,000 | — | 31 Dec 2018 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
205,379
|
$5,328,000 | — | 31 Dec 2018 | |
| Governors Lane LP |
13F
|
Company |
0.1%
|
180,802
|
$4,690,000 | — | 31 Dec 2018 |
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2019
As of 31 Mar 2019,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,662,760 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, BlackRock Inc., STATE STREET CORP, and ArrowMark Colorado Holdings LLC.
This page lists
189
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
169
Q1 2019 holders
189
Holder diff
20
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 Value $ | Q1 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.